EMERYVILLE, Calif., April 27 /PRNewswire-FirstCall/ -- Onyx
Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present
at the Morgan Stanley Global Healthcare Unplugged conference on Friday, May
4, at 11:00 a.m. Eastern Time. Interested parties may access a live webcast
of the presentation at:
http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=ONXX&item_id=1527767
It is recommended that listeners log on 15 minutes early in order to
register and download any necessary software. For those unable to
participate during the live webcast, a recorded replay of the presentation
will be available within 24 hours of the completion of the presentation
through June 4, 2007.
Onyx Pharmaceuticals, Inc. is a biopharmaceutical company developing
innovative therapies that target the molecular mechanisms that cause
cancer. The company is developing Nexavar(R), a small molecule drug, with
Bayer Pharmaceuticals Corporation. Nexavar has been approved for the
treatment of advanced kidney cancer. For more information about Onyx's
pipeline and activities, visit the company's web site at:
http://www.onyx-pharm.com.
Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer
Pharmaceuticals Corporation.
SOURCE Onyx Pharmaceuticals, Inc.
 back to top
Related links:
http://www.onyx-pharm.com/
CONTACT:
Alexandra Santos of Onyx Pharmaceuticals,
Inc., +1-510-597-6504
|
